EFSA reveals several areas of concern in novel food applications

novel food

The European Food Safety Authority (EFSA) has found several key areas of concern in novel food submissions it has received for CBD.   Among the areas of primary concern are missing information on applications and data gaps, which would support the evaluation of safety profiles, according to information shared during an EFSA-led webinar on 29 June.  […]

EFSA suspends novel food applications due to ‘data gaps and uncertainties’ 

lab tests

The European Food Safety Authority (EFSA) has ‘stopped the clock’ on 19 novel food applications for CBD, pending new data. The EU authority says its scientists cannot currently establish the safety of CBD as a novel food due to data gaps and uncertainties about potential hazards related to CBD intake. The news follows the submission […]

Back on track: Swiss ingredients manufacturer Linnea reinstated on FSA’s CBD list 

a green correct mark

Linnea, the expert manufacturer of botanical extracts for the pharmaceutical industry, has had its novel foods application reinstated by the Food Standards Agency, following its removal from the list earlier this year.  Cannabinoid Insight understands the company was originally told its application had been validated, only for the FSA to later rule Linnea out due […]

FSA issues clarification and new deadline for toxicology data

A number of CBD companies have until 28 February to provide sufficient toxicology data to the Food Standards Agency, or risk losing the right to sell their products.  Cannabinoid Insight has learnt that up to 40 CBD companies which submitted summary data on epilepsy drug Epidiolex in their novel foods application, have until 28 February […]